{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,16]],"date-time":"2026-07-16T08:43:35Z","timestamp":1784191415158,"version":"3.55.0"},"reference-count":42,"publisher":"Elsevier BV","issue":"4","license":[{"start":{"date-parts":[[2011,1,1]],"date-time":"2011-01-01T00:00:00Z","timestamp":1293840000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Vaccine"],"published-print":{"date-parts":[[2011,1]]},"DOI":"10.1016\/j.vaccine.2010.11.009","type":"journal-article","created":{"date-parts":[[2010,11,15]],"date-time":"2010-11-15T09:10:47Z","timestamp":1289812247000},"page":"813-820","source":"Crossref","is-referenced-by-count":13,"title":["Envelope protein E1 as vaccine target for western equine encephalitis virus"],"prefix":"10.1016","volume":"29","author":[{"given":"Richard D.","family":"Swayze","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hardeep S.","family":"Bhogal","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nicole D.","family":"Barab\u00e9","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lori J.","family":"McLaws","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Josh Q.H.","family":"Wu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.vaccine.2010.11.009_bib0005","series-title":"Fields virology","first-page":"1000","article-title":"Togaviridae: the viruses and their replication","author":"Kuhn","year":"2007"},{"key":"10.1016\/j.vaccine.2010.11.009_bib0010","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1099\/0022-1317-81-1-151","article-title":"Complete genomic RNA sequence of western equine encephalitis virus and expression of the structural genes","volume":"81","author":"Netolitzky","year":"2000","journal-title":"J Gen Virol"},{"key":"10.1016\/j.vaccine.2010.11.009_bib0015","doi-asserted-by":"crossref","first-page":"491","DOI":"10.1128\/MMBR.58.3.491-562.1994","article-title":"The alphaviruses: gene expression, replication, and evolution","volume":"58","author":"Strauss","year":"1994","journal-title":"Microbiol Rev"},{"key":"10.1016\/j.vaccine.2010.11.009_bib0020","doi-asserted-by":"crossref","first-page":"38","DOI":"10.1016\/j.virol.2005.09.036","article-title":"Class II virus membrane fusion proteins","volume":"344","author":"Kielian","year":"2006","journal-title":"Virology"},{"key":"10.1016\/j.vaccine.2010.11.009_bib0025","series-title":"Fields virology","first-page":"1023","article-title":"Alphavirus","author":"Griffin","year":"2007"},{"key":"10.1016\/j.vaccine.2010.11.009_bib0030","doi-asserted-by":"crossref","first-page":"227","DOI":"10.1126\/science.74.1913.227","article-title":"The etiology of epizootic encephalomyelitis of horses in the San Joaquin Valley, 1930","volume":"74","author":"Meyer","year":"1931","journal-title":"Science"},{"key":"10.1016\/j.vaccine.2010.11.009_bib0035","doi-asserted-by":"crossref","first-page":"455","DOI":"10.1126\/science.88.2289.455","article-title":"Recovery of the virus of equine encephalomyelitis from the brain of a child","volume":"88","author":"Howitt","year":"1938","journal-title":"Science"},{"key":"10.1016\/j.vaccine.2010.11.009_bib0040","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1128\/CMR.7.1.89","article-title":"Medically important arboviruses of the United States and Canada","volume":"7","author":"Calisher","year":"1994","journal-title":"Clin Microbiol Rev"},{"key":"10.1016\/j.vaccine.2010.11.009_bib0045","series-title":"The arboviruses: epidemiology and ecology","first-page":"89","article-title":"Western equine encephalomyelitis","author":"Reisen","year":"1989"},{"key":"10.1016\/j.vaccine.2010.11.009_bib0050","doi-asserted-by":"crossref","first-page":"170","DOI":"10.1016\/j.virol.2008.08.012","article-title":"Western equine encephalitis submergence: lack of evidence for a decline in virus virulence","volume":"380","author":"Forrester","year":"2008","journal-title":"Virology"},{"key":"10.1016\/j.vaccine.2010.11.009_bib0055","doi-asserted-by":"crossref","first-page":"681","DOI":"10.4269\/ajtmh.2008.78.681","article-title":"Limited interdecadal variation in mosquito (Diptera: Culicidae) and avian host competence for western equine encephalomyelitis virus (Togaviridae: Alphavirus)","volume":"78","author":"Reisen","year":"2008","journal-title":"Am J Trop Med Hyg"},{"key":"10.1016\/j.vaccine.2010.11.009_bib0060","doi-asserted-by":"crossref","first-page":"1173","DOI":"10.1086\/444397","article-title":"Aerosol exposure to western equine encephalitis virus causes fever and encephalitis in cynomolgus macaques","volume":"192","author":"Reed","year":"2005","journal-title":"J Infect Dis"},{"key":"10.1016\/j.vaccine.2010.11.009_bib0065","doi-asserted-by":"crossref","first-page":"1283","DOI":"10.1126\/science.158.3806.1283","article-title":"Arbovirus infections of laboratory workers. Extent of problem emphasizes the need for more effective measures to reduce hazards","volume":"158","author":"Hanson","year":"1967","journal-title":"Science"},{"key":"10.1016\/j.vaccine.2010.11.009_bib0070","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1016\/S0166-3542(02)00203-6","article-title":"Viruses of the Bunya- and Togaviridae families: potential as bioterrorism agents and means of control","volume":"57","author":"Sidwell","year":"2003","journal-title":"Antiviral Res"},{"key":"10.1016\/j.vaccine.2010.11.009_bib0075","series-title":"Textbook of military medicine part I: warfare, weaponry, and the casualty. Medical aspects of chemical and biological warfare","first-page":"561","article-title":"Viral encephalitides","author":"Smith","year":"1997"},{"key":"10.1016\/j.vaccine.2010.11.009_bib0080","doi-asserted-by":"crossref","first-page":"218","DOI":"10.4269\/ajtmh.2003.68.218","article-title":"Limited potential for mosquito transmission of genetically engineered, live-attenuated western equine encephalitis virus vaccine candidates","volume":"68","author":"Turell","year":"2003","journal-title":"Am J Trop Med Hyg"},{"key":"10.1016\/j.vaccine.2010.11.009_bib0085","doi-asserted-by":"crossref","first-page":"4309","DOI":"10.1016\/j.vaccine.2009.05.011","article-title":"Chimeric alphavirus vaccine candidates protect mice from intranasal challenge with western equine encephalitis virus","volume":"27","author":"Atasheva","year":"2009","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2010.11.009_bib0090","doi-asserted-by":"crossref","first-page":"2280","DOI":"10.1016\/j.vaccine.2005.01.032","article-title":"Efficacy of DNA vaccination against western equine encephalitis virus infection","volume":"23","author":"Nagata","year":"2005","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2010.11.009_bib0095","doi-asserted-by":"crossref","first-page":"1333","DOI":"10.1038\/mt.2009.130","article-title":"New insights on adenovirus as vaccine vectors","volume":"17","author":"Lasaro","year":"2009","journal-title":"Mol Ther"},{"key":"10.1016\/j.vaccine.2010.11.009_bib0100","doi-asserted-by":"crossref","first-page":"e177","DOI":"10.1371\/journal.pmed.0030177","article-title":"Immune protection of nonhuman primates against Ebola virus with single low-dose adenovirus vectors encoding modified GPs","volume":"3","author":"Sullivan","year":"2006","journal-title":"PLoS Med"},{"key":"10.1016\/j.vaccine.2010.11.009_bib0105","doi-asserted-by":"crossref","first-page":"205","DOI":"10.1016\/j.virol.2005.04.014","article-title":"Rapid protection of cattle from direct challenge with foot-and-mouth disease virus (FMDV) by a single inoculation with an adenovirus-vectored FMDV subunit vaccine","volume":"337","author":"Pacheco","year":"2005","journal-title":"Virology"},{"key":"10.1016\/j.vaccine.2010.11.009_bib0110","doi-asserted-by":"crossref","first-page":"1673","DOI":"10.1089\/104303403322542310","article-title":"Protective immunity evoked against anthrax lethal toxin after a single intramuscular administration of an adenovirus-based vaccine encoding humanized protective antigen","volume":"14","author":"Tan","year":"2003","journal-title":"Hum Gene Ther"},{"key":"10.1016\/j.vaccine.2010.11.009_bib0115","doi-asserted-by":"crossref","first-page":"e5308","DOI":"10.1371\/journal.pone.0005308","article-title":"Enhanced protection against Ebola virus mediated by an improved adenovirus-based vaccine","volume":"4","author":"Richardson","year":"2009","journal-title":"PLoS One"},{"key":"10.1016\/j.vaccine.2010.11.009_bib0120","doi-asserted-by":"crossref","first-page":"283","DOI":"10.1089\/vim.2005.18.283","article-title":"Adenoviral vectors for mucosal vaccination against infectious diseases","volume":"18","author":"Santosuosso","year":"2005","journal-title":"Viral Immunol"},{"key":"10.1016\/j.vaccine.2010.11.009_bib0125","doi-asserted-by":"crossref","first-page":"367","DOI":"10.1038\/gt.2008.181","article-title":"An adenoviral vector-based mucosal vaccine is effective in protection against botulism","volume":"16","author":"Xu","year":"2009","journal-title":"Gene Ther"},{"key":"10.1016\/j.vaccine.2010.11.009_bib0130","doi-asserted-by":"crossref","first-page":"1881","DOI":"10.1016\/S0140-6736(08)61591-3","article-title":"Efficacy assessment of a cell-mediated immunity HIV-1 vaccine (the Step Study): a double-blind, randomised, placebo-controlled, test-of-concept trial","volume":"372","author":"Buchbinder","year":"2008","journal-title":"Lancet"},{"key":"10.1016\/j.vaccine.2010.11.009_bib0135","doi-asserted-by":"crossref","first-page":"1894","DOI":"10.1016\/S0140-6736(08)61592-5","article-title":"HIV-1 vaccine-induced immunity in the test-of-concept Step Study: a case-cohort analysis","volume":"372","author":"McElrath","year":"2008","journal-title":"Lancet"},{"key":"10.1016\/j.vaccine.2010.11.009_bib0140","doi-asserted-by":"crossref","first-page":"1285","DOI":"10.1128\/CVI.00144-09","article-title":"Safety and immunogenicity of the Merck adenovirus serotype 5 (MRKAd5) and MRKAd6 human immunodeficiency virus type 1 trigene vaccines alone and in combination in healthy adults","volume":"16","author":"Harro","year":"2009","journal-title":"Clin Vaccine Immunol"},{"key":"10.1016\/j.vaccine.2010.11.009_bib0145","doi-asserted-by":"crossref","first-page":"4368","DOI":"10.1016\/j.vaccine.2007.03.042","article-title":"Complete protection of mice against a lethal dose challenge of western equine encephalitis virus after immunization with an adenovirus-vectored vaccine","volume":"25","author":"Wu","year":"2007","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2010.11.009_bib0150","doi-asserted-by":"crossref","first-page":"6271","DOI":"10.1016\/j.vaccine.2007.05.054","article-title":"Single-dose, fast-acting vaccine candidate against western equine encephalitis virus completely protects mice from intranasal challenge with different strains of the virus","volume":"25","author":"Barabe","year":"2007","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2010.11.009_bib0155","doi-asserted-by":"crossref","first-page":"2509","DOI":"10.1073\/pnas.95.5.2509","article-title":"A simplified system for generating recombinant adenoviruses","volume":"95","author":"He","year":"1998","journal-title":"Proc Natl Acad Sci USA"},{"key":"10.1016\/j.vaccine.2010.11.009_bib0160","series-title":"Virology methods manual","author":"Mahy","year":"1996"},{"key":"10.1016\/j.vaccine.2010.11.009_bib0165","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1089\/02724570050031158","article-title":"Construction and characterization of monoclonal antibodies against western equine encephalitis virus","volume":"19","author":"Long","year":"2000","journal-title":"Hybridoma"},{"key":"10.1016\/j.vaccine.2010.11.009_bib0170","doi-asserted-by":"crossref","first-page":"2353","DOI":"10.1099\/vir.0.81815-0","article-title":"Infectivity variation and genetic diversity among strains of western equine encephalitis virus","volume":"87","author":"Nagata","year":"2006","journal-title":"J Gen Virol"},{"key":"10.1016\/j.vaccine.2010.11.009_bib0175","doi-asserted-by":"crossref","first-page":"176","DOI":"10.1128\/CVI.00377-09","article-title":"Identification of western equine encephalitis virus structural proteins that confer protection after DNA vaccination","volume":"17","author":"Gauci","year":"2010","journal-title":"Clin Vaccine Immunol"},{"key":"10.1016\/j.vaccine.2010.11.009_bib0180","doi-asserted-by":"crossref","first-page":"127","DOI":"10.1128\/JVI.76.1.127-135.2002","article-title":"Adenovirus hexon protein is a potent adjuvant for activation of a cellular immune response","volume":"76","author":"Molinier-Frenkel","year":"2002","journal-title":"J Virol"},{"key":"10.1016\/j.vaccine.2010.11.009_bib0185","doi-asserted-by":"crossref","first-page":"1151","DOI":"10.1016\/S0264-410X(98)00335-1","article-title":"Expression, processing, and immunogenicity of the structural proteins of Venezuelan equine encephalitis virus from recombinant baculovirus vectors","volume":"17","author":"Hodgson","year":"1999","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2010.11.009_bib0190","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1016\/S0166-3542(04)00126-3","article-title":"Evaluation of a western equine encephalitis recombinant E1 protein for protective immunity and diagnostics","volume":"64","author":"Das","year":"2004","journal-title":"Antiviral Res"},{"key":"10.1016\/j.vaccine.2010.11.009_bib0195","doi-asserted-by":"crossref","first-page":"94","DOI":"10.1126\/science.274.5284.94","article-title":"Phenotypic analysis of antigen-specific T lymphocytes","volume":"274","author":"Altman","year":"1996","journal-title":"Science"},{"key":"10.1016\/j.vaccine.2010.11.009_bib0200","doi-asserted-by":"crossref","first-page":"70","DOI":"10.1038\/297070a0","article-title":"Non-neutralizing monoclonal antibodies can prevent lethal alphavirus encephalitis","volume":"297","author":"Schmaljohn","year":"1982","journal-title":"Nature"},{"key":"10.1016\/j.vaccine.2010.11.009_bib0205","doi-asserted-by":"crossref","first-page":"215","DOI":"10.2174\/156652306776359478","article-title":"Current strategies and future directions for eluding adenoviral vector immunity","volume":"6","author":"Bangari","year":"2006","journal-title":"Curr Gene Ther"},{"key":"10.1016\/j.vaccine.2010.11.009_bib0210","doi-asserted-by":"crossref","first-page":"761","DOI":"10.1586\/erv.09.29","article-title":"Strategies to overcome host immunity to adenovirus vectors in vaccine development","volume":"8","author":"Thacker","year":"2009","journal-title":"Expert Rev Vaccines"}],"container-title":["Vaccine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0264410X10016038?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0264410X10016038?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2020,6,13]],"date-time":"2020-06-13T20:39:15Z","timestamp":1592080755000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0264410X10016038"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2011,1]]},"references-count":42,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2011,1]]}},"alternative-id":["S0264410X10016038"],"URL":"https:\/\/doi.org\/10.1016\/j.vaccine.2010.11.009","relation":{},"ISSN":["0264-410X"],"issn-type":[{"value":"0264-410X","type":"print"}],"subject":[],"published":{"date-parts":[[2011,1]]}}}